G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...
It seems like no matter what I do, I can’t lose weight. Most of my family members struggle with their weight too. Do our ...
Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...
A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...
Taking semaglutide before bariatric surgery does not improve weight loss or safety, reveals research
Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...
Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.
Denmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the ...
Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...
Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...
Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback